Royalty Pharma Plc (RPRX) — Cash Flow Reinvestment Rate
Royalty Pharma Plc (RPRX) has a Cash Flow Reinvestment Rate of 0.62x as of March 2026, reinvesting $470.17 Million (capex $0.00 plus investments $-470.17 Million) from operating cash flow of $760.54 Million. See RPRX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Royalty Pharma Plc Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for Royalty Pharma Plc across 11 annual periods. For the full cash flow conversion analysis, see RPRX cash flow conversion.
Annual Cash Flow Reinvestment Rate for Royalty Pharma Plc (2002–2025)
Year-by-year capital reinvestment analysis for Royalty Pharma Plc. See Royalty Pharma Plc (RPRX) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | $1.36 Billion | $2.49 Billion | $0.00 | ▼ -43.3% |
| 2024 | 0.97x | $2.68 Billion | $2.77 Billion | $0.00 | ▲ +4.2% |
| 2023 | 0.93x | $2.77 Billion | $2.99 Billion | $2.12 Billion | ▼ -37.7% |
| 2022 | 1.49x | $3.19 Billion | $2.14 Billion | $2.04 Billion | ▲ +64.0% |
| 2021 | 0.91x | $1.83 Billion | $2.02 Billion | $523.00K | ▼ -65.1% |
| 2020 | 2.60x | $5.29 Billion | $2.03 Billion | $2.20 Billion | ▲ +13.0% |
| 2019 | 2.30x | $3.84 Billion | $1.67 Billion | $1.72 Billion | ▲ +342.1% |
| 2018 | 0.52x | $842.61 Million | $1.62 Billion | $269.59 Million | ▼ -74.3% |
| 2017 | 2.03x | $2.88 Billion | $1.42 Billion | $2.29 Billion | — |
| 2003 | 0.00x | $0.00 | $11.15 Million | $0.00 | ▼ -100.0% |
| 2002 | 0.01x | $49.00K | $8.45 Million | $49.00K | — |